The Diagnostic Performance of 24-hour Urinary Aldosterone for Primary Aldosteronism
Accuracy of 24-hour Urinary Aldosterone Testing in Diagnosing Primary Aldosteronism and Analysis of Drug Interference Factors
Sponsor: Zhiming Zhu
A observational or N/A phase clinical study on Hypertension and Primary Aldosteronism, this trial is completed. The trial is conducted by Zhiming Zhu and has accumulated 4 data snapshots since 2022. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
4 versions recorded-
May 2025 — Present [monthly]
Completed
Status: Recruiting → Completed
-
Sep 2024 — May 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Mar 2024 — Jul 2024 [monthly]
Recruiting
First recorded
Mar 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Zhiming Zhu
For direct contact, visit the study record on ClinicalTrials.gov .